Wednesday, April 05, 2006 7:07:03 PM
Well you should tell STTK that, in their most recent 10-Q they catagorize it as a liability and call it a "Bank Overdraft" on page 4. They also list no "Cash" as assets. If they had cash collateralizing a line of credit they should have entries in both catagories.
I wonder if there are more "problems" like this in STTK's accounting. LOL
Here's a few more interesting tidbits from the 10-Q
Bonus payable $302,768
Amounts due officers and directors $242,532
Total shareholder deficit -$422,796
Almost amazing that some company like this would be allowed to even be public.
There is apparently one mistake on Stocklemons report that I saw...
He quotes "apparent shares outstanding" as 73 mm but as of yesterday STTK's stock transfer agent quoted me 106 mm shares. If I was long this stock I would be worried about the apparent 45% dilution within the last few months.
I wonder if there are more "problems" like this in STTK's accounting. LOL
Here's a few more interesting tidbits from the 10-Q
Bonus payable $302,768
Amounts due officers and directors $242,532
Total shareholder deficit -$422,796
Almost amazing that some company like this would be allowed to even be public.
There is apparently one mistake on Stocklemons report that I saw...
He quotes "apparent shares outstanding" as 73 mm but as of yesterday STTK's stock transfer agent quoted me 106 mm shares. If I was long this stock I would be worried about the apparent 45% dilution within the last few months.
Recent TREP News
- Afinida Appoints Norman Tipton as Interim CEO to Lead During Executive Transition • ACCESS Newswire • 12/01/2025 02:00:00 PM
- Afinida Reports $16.9M in Q3 2025 Revenue, Expands Subsidiary Growth • ACCESS Newswire • 11/19/2025 02:00:00 PM
